<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="https://ontobee.org/ontology/view/MPIO?iri=http://purl.obolibrary.org/obo/MPIO_0000005"?>
<rdf:RDF xmlns="http://www.w3.org/2002/07/owl#"
     xml:base="http://www.w3.org/2002/07/owl"
     xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
     xmlns:owl="http://www.w3.org/2002/07/owl#"
     xmlns:oboInOwl="http://www.geneontology.org/formats/oboInOwl#"
     xmlns:xsd="http://www.w3.org/2001/XMLSchema#"
     xmlns:rdfs="http://www.w3.org/2000/01/rdf-schema#"
     xmlns:foaf="http://xmlns.com/foaf/0.1/"
     xmlns:dc="http://purl.org/dc/elements/1.1/"
     xmlns:ns3="http://purl.obolibrary.org/obo/">
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Annotation properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/MPIO_0000001"/>
    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000115"/>
    <AnnotationProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000112"/>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Datatypes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Object Properties
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/IAO_0000136 -->

    <ObjectProperty rdf:about="http://purl.obolibrary.org/obo/IAO_0000136">
        <rdfs:label xml:lang="en">is about</rdfs:label>
    </ObjectProperty>
    


    <!-- 
    ///////////////////////////////////////////////////////////////////////////////////////
    //
    // Classes
    //
    ///////////////////////////////////////////////////////////////////////////////////////
     -->

    


    <!-- http://purl.obolibrary.org/obo/DINTO_000003 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/DINTO_000003">
        <rdfs:label xml:lang="en">DDI mechanism</rdfs:label>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/IAO_0000030 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/IAO_0000030">
        <rdfs:label xml:lang="en">information content entity</rdfs:label>
    </Class>
    


    <!-- http://purl.obolibrary.org/obo/MPIO_0000005 -->

    <Class rdf:about="http://purl.obolibrary.org/obo/MPIO_0000005">
        <rdfs:label xml:lang="en">mechanism of interaction information</rdfs:label>
        <rdfs:subClassOf rdf:resource="http://purl.obolibrary.org/obo/IAO_0000030"/>
        <rdfs:subClassOf>
            <Restriction>
                <onProperty rdf:resource="http://purl.obolibrary.org/obo/IAO_0000136"/>
                <someValuesFrom rdf:resource="http://purl.obolibrary.org/obo/DINTO_000003"/>
            </Restriction>
        </rdfs:subClassOf>
        <ns3:MPIO_0000001 xml:lang="en">An assertion about the process or the processes by which a drug-drug interaction clinical consequence occurs.</ns3:MPIO_0000001>
        <ns3:IAO_0000115 xml:lang="en">An information content entity that is about the process or processes by which a drug-drug interaction clinical consequence occurs</ns3:IAO_0000115>
        <ns3:IAO_0000112 xml:lang="en">Non-steroidal anti-inflammatory drugs (NSAIDs) have antiplatelet effects which increase the bleeding risk when combined with oral anticoagulants such as warfarin. The antiplatelet effect of NSAIDs lasts only as long as the NSAID is present in the circulation, unlike aspirin’s antiplatelet effect, which lasts for up to 2 weeks after aspirin is discontinued.</ns3:IAO_0000112>
        <ns3:IAO_0000112 xml:lang="en">Timolol is a nonselective beta-blocker, and timolol eye drops have been shown to produce systemic beta-blockade. Timolol is metabolized by CYP2D6, and patients who are deficient in CYP2D6 (PMs) have been shown to develop higher timolol plasma concentrations following timolol ophthalmic aqueous drops.</ns3:IAO_0000112>
    </Class>
</rdf:RDF>



<!-- Generated by the OWL API (version 3.2.4.1806) http://owlapi.sourceforge.net -->



